Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-07-09

Clinical Trial Update: Randomized Study of Coronary Revascularization Surgery With Injection of WJ-MSCs and Placement of an Epicardial Extracellular Matrix [Phase 1, Phase 2]

View source ↗

Summary

A randomized study evaluating coronary revascularization surgery with injections of Wharton's Jelly mesenchymal stem cells and epicardial extracellular matrix i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epicardial extracellular matrix (extracellular matrix scaffold)
  • WJ-MSCs (Wharton's Jelly mesenchymal stem cells) (mesenchymal stem cells)

Snippet

Sponsor: Hospital San Vicente Fundación | Conditions: Cardiovascular Diseases, Heart Failure | Phase 1, Phase 2 | Status: UNKNOWN